https://biostackventures.com/2020/12/birmingham-based-uab-spinoff-will-develop-treatments-for-cardio-pulmonary-diseases/2020-12-13T20:12:47-06:00https://biostackventures.com/2020/12/new-biotech-firm-spins-off-from-uab-eyes-cardio-pulmonary-market/2020-12-13T20:12:41-06:00https://biostackventures.com/2020/12/health-innovation-startup-resbiotech-spins-out-of-uab/2020-12-13T20:12:54-06:00